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Introduction
Infection of a prosthetic vascular graft is a serious
complication of vascular surgery that carries high
morbidity and mortality rates. Although a wide range
of microorganisms has been implicated, graft infection
is usually bacterial. Fungal prosthetic vascular infec-
tion is rare. Candida and Aspergillus species constitute
most of the infecting organisms. In this report, we
describe the first case of prosthetic aortobifemoral
infection due to Histoplasma capsulatum outside an
endemic area that was successfully treated with in situ
allograft.
Case Report
A 66-year-old non-immunocompromised French male
was admitted to the hospital because of fever,
anorexia, and weight loss for one month. His past
medical history was significant for an aortobifemoral
prosthetic graft inserted four years before because of
severe aortoiliac occlusive disease. The interval period
since the surgery was eventless and the patient did not
travelled outside the Lyon area. On admission,
physical examination showed hepatosplenomegaly,
lymphadenopathy and anal ulceration. Biopsy of this
latter revealed an inflammatory infiltrate. Cultures
were negative for bacteria and acid-fast bacilli but
surprisingly positive for H. capsulatum, although the
patient had never been in a known Histoplasma
endemic region and the organism has not been
identified elsewhere in the institution. A regional
reference laboratory strengthened this result. Disse-
minated histoplasmosis was confirmed with adrenal
involvement necessitating corticosteroids supplemen-
tation. Treatment with amphotericin B 1 mg/kg/d was
used initially and then amphotericin B lipid complex
at a dose of 5 mg/kg/d because of nephrotoxicity.
Despite he received more than 2500 mg of ampho-
tericin B, sepsis recurred one month later. In an effort
to define an intravascular focus of infection, he
underwent thoraco-abdominal computed tomography
scan that showed an unusual inflammatory aspect
of the aortic graft associated with a 30 mm retroperi-
toneal collection in proximity (Fig. 1). Percutaneous
drainage yielded purulent materiel and methenamin
silver staining demonstrated yeast forms compatible
with H. capsulatum, despite the fact that the patient
continued to receive high doses of antifungal therapy.
Therefore, the patient was transferred to the operating
room the next day. Surgical treatment consisted of
radical debridement and revascularisation was per-
formed by an aortobifemoral cryopreserved arterial
homograft. During the operation, the periaortic tissue
was notably inflamed. Operative specimens sent for
fungal culture were again positive for H. capsulatum.
After operation, he received a new therapeutic course
of amphotericin B lipid complex. His general status
improved gradually and he was discharged from the
intensive care unit. Nine months after, he has had no
recurrence of infection. Despite a deep investigation, it
was impossible to clearly define how the patient
becomes infected.
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Discussion
Histoplasmosis is an inhalation-acquired mycosis
which is asymptomatic in the great majority of
individuals infected.1 Initial infection is through the
lungs and is often subclinical. Hematogenous dis-
semination may occur, resulting in a disease with
protean manifestations. The two factors that govern
the degree of symptomatology are the quantity of
inoculum inhaled and the immune status of the host.
Thus, progressive dissemination occurs primarily in
those who are immunocompromised or those at the
extremes of age. This dimorphic fungus, meaning it
can grow as mycelial form at ambient temperatures
and as a yeast form at body temperature, is endemic
surround the central river valleys of the United States
and certain other river valleys of the world between
latitude 458 North and 308 South of the equator. Precise
reasons for this endemic distribution pattern are
unknown. To our knowledge, based upon a MEDLINE
review, our case represents the first report of
H. capsulatum infecting an aortobifemoral prosthetic
graft outside of an endemic area, and only the third case
in the world. The previous two cases were reported from
the United States and, as in our case, occurred in the
setting of disseminated histoplasmosis.2,3 Unlike our
patient’s case, replacement with a vascular prosthesis
was done in the same anatomic location. In one of the
two, despite administration of adequate antifungal
therapy, infection persisted and the patient died. It is
difficult to make definite conclusion regarding medical
and surgical management of H. capsulatum-infected
prosthetic vascular graft because of the few cases
reported. However, nowadays standard management
of aortic vascular graft infection involves complete
excision of infected tissue and revascularisation via
extra-anatomic pathways or with in situ allografts.4
Surgery should be completed by intensive care and
aggressive supportive treatment in combination with
antifungal therapy to optimised chances for cure. First-
line treatment is amphotericin B given intravenously
in a dosage of 0.7–1.0 mg/kg/d. When the patient’s
situation improves until is able to take oral medi-
cations, itraconazole 200 po daily for 6–18 months
may be substituted.5 Ketoconazole 400 mg po daily is
also effective, less costly, but less well-tolerated.
Fluconazole 400–800 mg daily is an alternative for
patients who cannot take itraconazole. However,
H. capsulatum may develop resistance during flucona-
zole therapy, leading to relapse.
This case highlights the possibility of H. capsulatum
infection of a prosthetic vascular graft, an uncommon
but devastating complication, in non-endemic areas.
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Fig. 1. Abdominal CT scan demonstrates an abnormal aspect
of the aortic graft with a retroperitoneal collection.
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